Source:http://linkedlifedata.com/resource/pubmed/id/10910074
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
13
|
| pubmed:dateCreated |
2000-8-17
|
| pubmed:abstractText |
p53 abnormalities constitute the most frequent genetic alterations identified in larynx cancers. p53 overexpression in histologically "tumor-free" surgical margins correlates with a high recurrence rate. However, only 50-60% of tumors overexpress p53. The tumor marker eIF4E is overexpressed in 100% of larynx cancers, and overexpression of eIF4E in histologically "tumor-free" margins predicts a significantly higher recurrence. We undertook this study to correlate the expression of p53 and eIF4E in the tumors and surgical margins of squamous cell cancers of the larynx and to determine their prognostic value. A retrospective analysis was performed on 54 patients who underwent surgery for squamous cell cancers of the larynx. Patient and tumor characteristics were reviewed, and the time to recurrence was noted. Paraffin-embedded sections from the tumors and surgical margins were immunostained with antibodies to eIF4E and p53, and a qualitative analysis was performed. All 54 patients (100%) overexpressed eIF4E in the primary tumor, whereas 25 of 53 patients (47%) were p53 positive. Thirty-two of the 54 patients (59%) had eIF4E-positive margins. All 6 of 53 patients (11%) with p53-positive margins also overexpressed eIF4E in the margins. There was a significant correlation between p53 and eIF4E being positive in the margins (Spearman's correlation coefficient, P = 0.03). Twenty-one of the 25 patients (84%) that recurred, including the 6 patients with p53-positive margins, had eIF4E-positive margins. Hence, although the univariate analysis showed that nodal status and both eIF4E and p53 expression in the margins were significant predictors of recurrence (P < 0.05), in the multivariate analyses only nodal status (P < 0.001) and eIF4E in the margins (P < 0.001) were significant predictors of recurrence. Kaplan-Meier analysis demonstrated that the disease-free intervals for eIF4E-positive margins were significantly shorter than eIF4E-negative margins (P = 0.0007). There was no additional effect to the combination of positive p53 and eIF4E margins (P = 0.21). The overexpression of eIF4E in the margins appears to be a more sensitive indicator of recurrence and may be an earlier event in the process of tumorigenesis than p53.
|
| pubmed:grant | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jul
|
| pubmed:issn |
0008-5472
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
1
|
| pubmed:volume |
60
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
3599-604
|
| pubmed:dateRevised |
2007-11-14
|
| pubmed:meshHeading |
pubmed-meshheading:10910074-Analysis of Variance,
pubmed-meshheading:10910074-Carcinoma, Squamous Cell,
pubmed-meshheading:10910074-Disease-Free Survival,
pubmed-meshheading:10910074-Eukaryotic Initiation Factor-4E,
pubmed-meshheading:10910074-Female,
pubmed-meshheading:10910074-Follow-Up Studies,
pubmed-meshheading:10910074-Genes, p53,
pubmed-meshheading:10910074-Humans,
pubmed-meshheading:10910074-Laryngeal Neoplasms,
pubmed-meshheading:10910074-Male,
pubmed-meshheading:10910074-Middle Aged,
pubmed-meshheading:10910074-Neoplasm Staging,
pubmed-meshheading:10910074-Peptide Initiation Factors,
pubmed-meshheading:10910074-Predictive Value of Tests,
pubmed-meshheading:10910074-Prognosis,
pubmed-meshheading:10910074-Retrospective Studies,
pubmed-meshheading:10910074-Time Factors,
pubmed-meshheading:10910074-Treatment Outcome,
pubmed-meshheading:10910074-Tumor Suppressor Protein p53
|
| pubmed:year |
2000
|
| pubmed:articleTitle |
Correlation of p53 and the proto-oncogene eIF4E in larynx cancers: prognostic implications.
|
| pubmed:affiliation |
Department of Otolaryngology/Head and Neck Surgery, Louisiana State University Health Sciences Center and Veterans Administration Medical Center, Shreveport 71130, USA. cnatha@lsumc.edu
|
| pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|